← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Budesonide currently has availability issues reported in 5 European registers: Austria, Germany, Greece, Ireland, Sweden.
Shortage ATC R03BA02 · also listed as: BUDESONID · BUDESONIDE · data refreshed 11 September 2026
As of 11 September 2026, 5 of the 9 tracked registers list current availability issues for Budesonide, covering 8 affected product presentations. The longest-running open report was filed in Austria on 2021-06-15 and has now been open for about 63 months. Where agencies state a cause, manufacturing problems lead with 2 of the 4 stated-cause reports, followed by unexpectedly high demand with 1. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-21. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Austria reported first (2021-06-15), with Greece following roughly 61 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Ireland, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Budesonide is coded R03BA02 — a medicine acting on the respiratory system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage CortimentMMX 9 mg - Retardtabletten | 2021-06-15 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Cyclocaps Budesonid 200 µg | 2025-08-01 | 2026-12-31 | Erhöhte Nachfrage Alternatives: Cyclocaps Budesonid 400 µg - Einreichungsnummer: 2146412 | register ↗ |
| 🇬🇷 Greece | Limited availability CAN x 14 ACTUATIONS | 2026-07-28 | 2026-08-28 | GALENICA ΑΕ Καθυστέρηση παράδοσης Εναλλακτικά άλλο σκεύασμα της ίδιας | register ↗ |
| 🇮🇪 Ireland | Shortage Budesonide Teva Pharma 0.5 mg / 2 ml Nebuliser Suspension + 2 more productsBudesonide Teva Pharma 1 mg / 2 ml Nebuliser Suspension Pinacort 3 mg modified release hard capsules | 2024-11-11 | 2026-09-30 | Manufacturing delay (Global) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇸🇪 Sweden | Shortage Budenofalk 3 mg Enterokapsel, hård + 1 more productsBudesonide Teva Pharma 0,5 mg/ml Suspension för nebulisator | 2025-09-15 | 2026-09-30 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Budesonide in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Budenofalk 3 mg Enterokapsel, hård | Expected shortage | 2026-07-31 | 2026-09-21 | |
| 🇬🇷 GR | CAN x 14 ACTUATIONS | Limited availability | 2026-07-28 | 2026-08-28 | GALENICA ΑΕ Καθυστέρηση παράδοσης Εναλλακτικά άλλο σκεύασμα |
| 🇮🇪 IE | Pinacort 3 mg modified release hard capsules | Shortage | 2025-10-28 | — | |
| 🇸🇪 SE | Budesonide Teva Pharma 0,5 mg/ml Suspension för nebulisator | Shortage | 2025-09-15 | 2026-09-30 | |
| 🇩🇪 DE | Cyclocaps Budesonid 200 µg | Shortage | 2025-08-01 | 2026-12-31 | Erhöhte Nachfrage |
| 🇮🇪 IE | Budesonide Teva Pharma 0.5 mg / 2 ml Nebuliser Suspension | Shortage | 2024-12-04 | 2026-08-14 | Manufacturing delay (Global) |
| 🇮🇪 IE | Budesonide Teva Pharma 1 mg / 2 ml Nebuliser Suspension | Shortage | 2024-11-11 | 2026-09-30 | Manufacturing delay (Multiple countries) |
| 🇦🇹 AT | CortimentMMX 9 mg - Retardtabletten | Shortage | 2021-06-15 | — |
Yes. As of 11 September 2026, availability issues are reported in: Austria, Germany, Greece, Ireland, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-21 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Budesonide: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece), HPRA (Ireland), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Budesonide — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/budesonide/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Budesonide availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/budesonide/">Budesonide shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>